Bristol Nears $3 Billion Deal to Sell Stake in Diabetes Venture to Astra

Bristol-Myers Squibb is nearing a deal to sell its stake in a diabetes partnership with AstraZeneca for more than $3 billion.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304367204579266821017884530.html?mod=pls_whats_news_us_business_f

via IFTTT